Regulation of Cell-Based Therapies in Europe: Current Challenges and Emerging Issues
Author:
Affiliation:
1. INSERM UMR 1027 Département d'épidémiologie et de santé publique, Faculté de Médecine, Université Paul Sabatier—Toulouse III, Toulouse, France.
Publisher
Mary Ann Liebert Inc
Subject
Cell Biology,Developmental Biology,Hematology
Link
https://www.liebertpub.com/doi/pdf/10.1089/scd.2013.0352
Reference14 articles.
1. Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive
2. Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development
3. The Legal Landscape for Advanced Therapies: Material and Institutional Implementation of European Union Rules in France and the United Kingdom
4. Fundamental Disjunctions in the EU Legal Order on Human Tissue, Cells & Advanced Regenerative Therapies
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Organizational aspects of tissue engineering clinical translation: insights from a qualitative case study;Translational Medicine Communications;2024-05-30
2. Stem Cell Therapies for the Treatment of Radiation and Chemotherapy Side Effects;Comprehensive Hematology and Stem Cell Research;2024
3. The variability of judicial decisions in the stem cell industry in China;Cell Stem Cell;2023-10
4. Stem cell-based combinatorial therapies for spinal cord injury: a narrative review of current research and future directions;Annals of Medicine & Surgery;2023-07-03
5. Education for the translation of Advanced Therapy Medicinal Products;Frontiers in Medicine;2023-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3